CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BIO-RAD LABORATORIES, INC.

BIO
$7.81B
Mid Cap
NASDAQLaboratory Analytical Instruments🇺🇸North AmericaHERCULES7.7K employees

Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide.

Website

Drugs in Pipeline

0

Phase 3 Programs

0

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

BIO News
Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

How BIO's past catalysts played out

Drug Pipeline

No drugs found in this phase.

Market-Implied Move
Regulatory Approvals

Frequently asked questions

When is BIO-RAD LABORATORIES, INC.'s next FDA catalyst?

CatalystAlert tracks every upcoming catalyst for BIO-RAD LABORATORIES, INC. (BIO) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track BIO biotech catalysts?

Add BIO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow BIO-RAD LABORATORIES, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply